News in the Life Sciences Industry

REYKJAVIK, Iceland and MUMBAI, India, July 29, 2019 /PRNewswire/ -- Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ; hereafter referred to as "Cipla"), today... Read more ››

SINGAPORE, July 26, 2019 /PRNewswire/ -- International healthcare organizations, Novartis and Mundipharma, have signed a landmark agreement for the marketing, sales and distribution rights of Novartis medicines in the general ophthalmology disease area in Taiwan of Novartis. This includes medicines... Read more ››

HONG KONG, July 24, 2019 /PRNewswire/ -- amg International GmbH (amg), a wholly owned subsidiary of Dublin, Ireland based Q3 Medical Devices Limited (Q3), announced that Professor Anthony Teoh of the Chinese University of Hong Kong, Prince of Wales Hospital successfully implanted the first ARCHIMEDES... Read more ››

MUMBAI, July 11, 2019 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), and Torrent Pharmaceuticals Limited (Torrent) today announced that they have entered into a non-exclusive sub-licensing agreement to co-market sodium glucose co-transporter-2 (SGLT2) inhibitor, Remogliflozin Etabonate... Read more ››

AHMEDABAD, India, July 9, 2019 /PRNewswire/ -- One of India's leading pharmaceutical companies, Intas Pharmaceuticals, takes a revolutionary step towards making therapy for chronic immune thrombocytopenia (ITP) more accessible to patients by being the first to launch Romiplostim in India... Read more ››

SINGAPORE, June 6, 2019 /PRNewswire/ -- Frost & Sullivan named some of Asia's leading companies recognized for their achievements in its recipients list for the Asia-Pacific Best Practices Awards earlier today.

SUZHOU, China, June 5, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the research data on the treatment of relapsed or refractory extranodal NK/T cell... Read more ››

SUZHOU, China, June 4, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the results of extended follow-up on sintilimab, the anti-PD-1 antibody that co-developed... Read more ››

TAIPEI, Taiwan, June 3, 2019 /PRNewswire/ -- The Innovation & Incubation Center (IAIC), an arm of the Executive Operation Office for Industry-Academia Cooperation at Chung Yuan Christian University (CYCU) hosted the International Venture Capital Investment Match event on May 27, 2019. Over... Read more ››